Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
LMU researchers show how genetic variant in people of African ancestry modulates immune cells

LMU researchers show how genetic variant in people of African ancestry modulates immune cells

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

FDA approves new drug to treat adults with moderate-to-severe plaque psoriasis

FDA approves new drug to treat adults with moderate-to-severe plaque psoriasis

FDA approves new therapy for initial treatment of soft tissue sarcoma

FDA approves new therapy for initial treatment of soft tissue sarcoma

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

BCL-2 inhibitor shows promise in AML patients

BCL-2 inhibitor shows promise in AML patients

Researchers identify specific pathways involved in development of mucormycosis

Researchers identify specific pathways involved in development of mucormycosis

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

Clinical trial to evaluate safety of palbociclib drug in African American women with breast cancer

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

New IDSA guidelines focus on diagnosis, treatment of deadly aspergillosis

New IDSA guidelines focus on diagnosis, treatment of deadly aspergillosis

Salvage inotuzumab ozogamicin improves ALL outcomes

Salvage inotuzumab ozogamicin improves ALL outcomes

Long-term dasatinib findings support first-line use in CML

Long-term dasatinib findings support first-line use in CML